Meet the SRT Board of Directors

John P. Cooke, M.D., Ph.D.
President
Medical Director, Center for RNA Therapeutics,
Chief Translational Officer,
Houston Methodist Academic Institute
Houston, TX USA

Bruce A. Sullenger, Ph.D.
Vice President
Joseph and Dorothy Beard Professor
Department of Surgery
Duke University
Durham, NC USA

Lior Zangi, Ph.D.
Secretary-Treasurer
Associate Professor, Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai
New York, NY USA

Annemieke Aartsma-Rus, Ph.D.
Professor of Translational Genetics,
Department of Human Genetics
Albinusdreef, Leiden The Netherlands

Virginia Arechavala-Gomeza, Ph.D.
Ikerbasque Research Professor
Group Leader, Nucleic Acid Therapeutics for Rare Diseases (NAT-RD),
Biocruces Bizkaia Health Research Institute
Barakaldo, Spain

Maria Carmo-Fonseca, M.D., Ph.D.
Immediate Past President, RNA Society
Group Leader, Instituto de Medicina Molecular
Lisbon, Portugal

Pieter R. Cullis, Ph.D., FRSC, FNAI (USA)
Professor, Department of Biochemistry and Molecular Biology - UBC
Founding Director, Centre for Drug Research and Development
Founding Scientific Director and CEO, NanoMedicines Innovation Network
Vancouver BC, Canada

Amanda E. Hargrove, Ph.D.
Associate Professor of Chemistry,
Duke University
Durham, NC USA

Michelle L. Hastings, Ph.D.
Pfizer Upjohn Research Professor of Pharmacology
Director, M-RNA Therapeutics
University of Michigan Medical School
Department of Pharmacology
Ann Arbor, MI USA

Adrian Krainer, Ph.D.
St. Giles Foundation Professor
Cancer Center Deputy Director of Research
Cold Spring Harbor Laboratory
Cold Spring Harbor, NY USA

Prof. Dan Peer, Ph.D.
Director, Laboratory of Precision
NanoMedicine, Shmunis School for Biomedicine and Cancer Research Tel Aviv University, Dept of Cell Research & Immunology
Ramat Aviv, Tel-Aviv Israel

Anna Marie Pyle Ph.D.
Sterling Professor of Molecular, Cellular and Developmental Biology and Professor of Chemistry,
Yale University
New Haven, CT USA